339 results on '"Halbach, Marcel"'
Search Results
2. Frailty, periinterventional complications and outcome in patients undergoing percutaneous mitral and tricuspid valve repair
3. „Sachkunde Arterielle Hypertonie“ der DGK
4. Prognostic impact of resting full-cycle ratio and diastolic non-hyperemic pressure ratios in patients with deferred revascularization
5. Kommentar zum Konsensuspapier zur renalen Denervation der Arbeitsgruppe Hypertonie der European Society of Cardiology (ESC) und der European Association of Percutaneous Cardiovascular Interventions (EAPCI)
6. Contemporary treatment of mitral valve disease with transcatheter mitral valve implantation
7. Disentangling Heart Failure and Physical Frailty: Prospective Study of Patients Undergoing Percutaneous Mitral Valve Repair
8. Comparison of vessel fractional flow reserve with invasive resting full-cycle ratio in patients with intermediate coronary lesions
9. Diagnostic performance of quantitative flow ratio versus fractional flow reserve and resting full-cycle ratio in intermediate coronary lesions
10. Prevalence of left ventricular thrombus formation after mitral valve edge-to-edge repair
11. Early in-hospital discontinuation of aspirin on the first post-procedural day after percutaneous coronary stent implantation in patients on direct oral anticoagulation
12. Baroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension
13. Persistence of intramyocardially transplanted murine induced pluripotent stem cell-derived cardiomyocytes from different developmental stages
14. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications
15. Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease
16. Sleep-disordered breathing in patients with cardiovascular diseases cannot be detected by ESS, STOP-BANG, and Berlin questionnaires
17. Correction to: Baroreflex activation therapy reduces frequency and duration of hypertension‑related hospitalizations in patients with resistant hypertension
18. Posterior myocardial infarction—a hidden ECG emergency presentation
19. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
20. Early in-hospital discontinuation of aspirin on the first postprocedural day after percutaneous coronary stent implantation in patients on direct oral anticoagulation.
21. Efficacy of Electrical Baroreflex Activation Is Independent of Peripheral Chemoreceptor Modulation
22. Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction
23. Cardiac Cell Replacement Therapy With Pluripotent Stem Cell Derived Cardiomyocytes
24. PS-BPC07-8: ARTERIAL HYPERTENSION AS PROGNOSTIC MARKER IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION AND EARLY PERCUTANEOUS CORONARY INTERVENTION
25. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction
26. Preconditioning of skeletal myoblast-based engineered tissue constructs enables functional coupling to myocardium in vivo
27. Contemporary treatment of mitral valve disease with transcatheter mitral valve implantation
28. Medizinische Perspektiven der kardilen Stammzellforschung
29. Combination of a subcutaneous ICD in a patient with a baroreceptor activation device: Feasibility, safety, and precautions: A Case Report
30. Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective
31. The Hypertension Paradox: Survival Benefit After ST-Elevation Myocardial Infarction in Patients With History of Hypertension. A Prospective Cohort- and Risk-Analysis
32. Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy
33. Prevalence of left ventricular thrombus formation after mitral valve edge-to-edge repair
34. Feasibility and Comparison of Resting Full-Cycle Ratio and Computed Tomography Fractional Flow Reserve in Patients with Severe Aortic Valve Stenosis
35. Feasibility and Comparison of Resting Full-Cycle Ratio and Computed Tomography Fractional Flow Reserve in Patients with Severe Aortic Valve Stenosis
36. The Hypertension Paradox: Survival Benefit After ST-Elevation Myocardial Infarction in Patients With History of Hypertension. A Prospective Cohort- and Risk-Analysis
37. sj-docx-1-tak-10.1177_17539447221131203 – Supplemental material for Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy
38. Hyperaldosteronism is associated with a decrease in number and altered growth factor expression of endothelial progenitor cells in rats
39. Cardiopulmonary function during exercise in heart failure with reduced ejection fraction following baroreflex activation therapy
40. Comparison of Resting Full-Cycle Ratio and Fractional Flow Reserve in a German Real-World Cohort
41. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy
42. Electrophysiological and Morphological Maturation of Murine Fetal Cardiomyocytes During Electrical Stimulation In Vitro
43. Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction
44. Additional file 3 of Persistence of intramyocardially transplanted murine induced pluripotent stem cell-derived cardiomyocytes from different developmental stages
45. ��ber den Einfluss k��nstlicher Lichtexposition am Morgen auf die Herzratenvariabilit��t im Menschen
46. Additional file 4 of Persistence of intramyocardially transplanted murine induced pluripotent stem cell-derived cardiomyocytes from different developmental stages
47. Arterial hypertension-What was important in 2020?
48. Comparison of Resting Full-Cycle Ratio and Fractional Flow Reserve in a German Real-World Cohort
49. Baroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension (vol 30, pg 541, 2020)
50. Baroreflex activation therapy in patients with pre-existing implantable cardioverter-defibrillator: compatible, complementary therapies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.